Bookmark

Add to MyYahoo RSS

Cyclacel Pharmaceuticals News

News on Cyclacel Pharmaceuticals (Ticker: CYCC) continually updated from thousands of sources around the net.

Wednesday Jun 18 | BioSpace

Cyclacel Pharmaceuticals, Inc. To Present At 9th Annual Healthcare Conference

Cyclacel Pharmaceuticals, Inc. , a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders today announced that the Company will present at the 9th Annual JMP Securities Healthcare Conference being held at The Westin New York Grand Central, ... (more)

Comment?

Related Topix: Biotech

Tue Jun 10, 2014

Seeking Alpha

Cyclacel Shapes Sapacitabine's Phase IIb Study For Regulatory Success

Cyclacel Pharmaceuticals is in the home stretch of a pivotal Phase III oncology trial that will serve to catalyze investor interest moving forward.

Comment?

Related Topix: Biotech

Thu Jun 05, 2014

Seeking Alpha

Cyclacel Pharmaceuticals: The Devil's Advocate Be Damned

Was any thought given to the consequences of engendering enormous expectations that would be met with underwhelming news? I hope not! Cyclacel's honored guest speaker at this invitation-only fiasco was Hagop Kantarjian, M.D., who was feisty, candid, bewildered and refreshing.

Comment?

Related Topix: Biotech

Sat May 31, 2014

GlobeNewswire

Cyclacel Pharmaceuticals Provides Update on Its Clinical Development...

Cyclacel Pharmaceuticals, Inc. , a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, announced plans for the clinical development of sapacitabine in a second potential indication for patients with myelodysplastic syndromes after ... (more)

Comment?

Related Topix: Biotech, Healthcare Law, Law, Leukemia, Health

Wed May 28, 2014

BioSpace

Cyclacel Pharmaceuticals, Inc. To Webcast Institutional Investor And...

Cyclacel Pharmaceuticals, Inc. , a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it will webcast an invitation-only institutional investor and analyst presentation from 6:30 p.m. to 8 p.m. CDT, Saturday, May 31, ... (more)

Comment?

Related Topix: Biotech

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••